← Open Payments lookup

MARK VELARDE: Open Payments

NPI 1578513560 · WESCOSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,283 in 63 payments from 18 companies in 2025. Trend: 2023 $1,698 · 2024 $1,457 · 2025 $1,283

Food & beverage: $1,213Education: $70
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$230
Lilly USA, LLC10$197
ABBVIE INC.10$182
Astellas Pharma US Inc3$103
Novo Nordisk Inc4$92
PFIZER INC.5$86
Exact Sciences Corporation3$72
Alnylam Pharmaceuticals Inc.3$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$58
Boehringer Ingelheim Pharmaceuticals, Inc.2$41

Products named: JARDIANCE, MOUNJARO, UBRELVY, QULIPTA, FARXIGA, NURTEC ODT, ONPATTRO, XIFAXAN.

Industry payments across PA — which companies pay providers there.